Genetic Analysis

Ronny Hermansen, CEO of Genetic Analysis AS, has through the fully owned company InVitroDia AS on Friday 22.11.2024 bought 73.400 GEAN shares at an average price of 0,42 NOK per share. The shares were acquired on the Spotlight Stock Market. Following the transaction, Ronny Hermansen including controlled company owns 1.113.600 shares and 716.668 options.

Lars Tiller, Head of Operations of Genetic Analysis AS, has on Friday 22.11.2024 bought 30.000 GEAN shares at an average price of 0,39 NOK per share. The shares were acquired on the Spotlight Stock Market. Following the transaction, Lars Tiller owns 93.291 shares and 210.000 options.

For further information, please contact:
Ronny Hermansen, CEO
E-mail: rh@genetic-analysis.com  

About Genetic Analysis:
Genetic Analysis AS (GA) is a science-based diagnostic company and pioneer in the human microbiome field with more than 15 years of expertise in research and product development. The unique GA-map® platform is based on a pre-determined multiplex targets approach specialized for simultaneous analysis of a large number of bacteria in one reaction. The test results are generated by utilizing the clinically validated cutting edge GA-map® software algorithm. This enables immediate results without the need for further bioinformatics work. GA’s vision is to become the leading company for standardized gut microbiota testing worldwide, and GA is committed to help unlocking and restoring the human microbiome through its state-of-the-art technology. GA employs a team of highly qualified employees with scientific backgrounds and competence in sales, operations, bioinformatics, molecular biology, and bioengineering.

For more general information: www.genetic-analysis.com

Stay updated on GA and sign up for more investor-related information: https://www.genetic-analysis.com/subscriptions/

Interested in reading more about GA's products? Please visit ga-map.com